Abstract | OBJECTIVE: ANIMALS: 483 foals born and raised on 12 equine breeding farms with a history of endemic R equi infections. PROCEDURES: Group 1 foals were treated with a placebo and group 2 foals were treated with gallium maltolate (approx 30 mg/kg, PO, q 24 h) during the first 2 weeks after birth. Foals were monitored for development of pneumonia attributable to R equi infection and for adverse effects of gallium maltolate. RESULTS: There were no significant differences in the cumulative incidence of R equi pneumonia among the 2 groups. CONCLUSIONS AND CLINICAL RELEVANCE:
Chemoprophylaxis via gallium maltolate administered orally at approximately 30 mg/kg daily for the first 2 weeks after birth failed to reduce the cumulative incidence of pneumonia attributable to R equi infection among foals on breeding farms with endemic R equi infections. Further investigation is needed to identify strategies for control of R equi infections.
|
Authors | M Keith Chaffin, Noah D Cohen, Ronald J Martens, Michael O'Conor, Lawrence R Bernstein |
Journal | American journal of veterinary research
(Am J Vet Res)
Vol. 72
Issue 7
Pg. 945-57
(Jul 2011)
ISSN: 1943-5681 [Electronic] United States |
PMID | 21728856
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Organometallic Compounds
- Pyrones
- gallium maltolate
|
Topics |
- Actinomycetales Infections
(epidemiology, prevention & control, veterinary)
- Animals
- Anti-Bacterial Agents
(therapeutic use)
- Antibiotic Prophylaxis
(veterinary)
- Female
- Horse Diseases
(epidemiology, prevention & control)
- Horses
(microbiology)
- Male
- Organometallic Compounds
(therapeutic use)
- Pneumonia, Bacterial
(epidemiology, prevention & control, veterinary)
- Pyrones
(therapeutic use)
- Rhodococcus equi
(drug effects, physiology)
|